- Home
- SNT vs NSPR Comparison
SNT vs NSPR Comparison
Compare SNT & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNT
- NSPR
- Stock Information
- Founded
- SNT 1965
- NSPR 2005
- Country
- SNT Canada
- NSPR Israel
- Employees
- SNT N/A
- NSPR N/A
- Industry
- SNT Telecommunications Equipment
- NSPR Medical/Dental Instruments
- Sector
- SNT Telecommunications
- NSPR Health Care
- Exchange
- SNT Nasdaq
- NSPR Nasdaq
- Market Cap
- SNT 64.6M
- NSPR 63.0M
- IPO Year
- SNT 1993
- NSPR N/A
- Fundamental
- Price
- SNT $3.45
- NSPR $2.93
- Analyst Decision
- SNT
- NSPR Strong Buy
- Analyst Count
- SNT 0
- NSPR 2
- Target Price
- SNT N/A
- NSPR $4.75
- AVG Volume (30 Days)
- SNT 73.4K
- NSPR 78.6K
- Earning Date
- SNT 11-12-2024
- NSPR 11-12-2024
- Dividend Yield
- SNT N/A
- NSPR N/A
- EPS Growth
- SNT N/A
- NSPR N/A
- EPS
- SNT 0.06
- NSPR N/A
- Revenue
- SNT $34,455,000.00
- NSPR $6,821,000.00
- Revenue This Year
- SNT N/A
- NSPR $13.31
- Revenue Next Year
- SNT N/A
- NSPR $52.91
- P/E Ratio
- SNT $54.86
- NSPR N/A
- Revenue Growth
- SNT 2.04
- NSPR 24.70
- 52 Week Low
- SNT $1.08
- NSPR $1.81
- 52 Week High
- SNT $3.35
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- SNT 71.93
- NSPR 52.69
- Support Level
- SNT $2.90
- NSPR $2.78
- Resistance Level
- SNT $3.09
- NSPR $3.15
- Average True Range (ATR)
- SNT 0.19
- NSPR 0.22
- MACD
- SNT 0.00
- NSPR -0.03
- Stochastic Oscillator
- SNT 98.16
- NSPR 47.58
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.